Liquid Biopsy Market 112017

Liquid Biopsy Market: Rising Cases of Lung Cancer Fuelling Adoption of Liquid Biopsy Across the World: Global Industry Analysis (2012 - 2016) and Opportunity Assessment (2017 - 2027)

Ask The Analyst Customization Available Request Methodology

Key Insights on the Liquid Biopsy Market

Increasing Effectiveness of Tumor Detection in Low Cost and Less Time

Traditional tissue biopsy, taken from primary tumor, reflects molecular composition of tumor at the time of sample taking – leaving heterogeneity of tumor undetected. In a liquid biopsy test sample taken from blood – a tumor’s entire range of probable malignancy’s properties are reflected. Reflections also include metastases and biochemical changes acquired during blood-borne dissemination. Liquid biopsy tests can also reflect intra-patient heterogeneity of tumor characteristics in a single sample. Early broad spectrum detection of tumor growth possibilities can prevent potential metastases. Liquid biopsy tests can access tumors that are not accessible by needle biopsies because of their remote location in the body. The minimally invasive nature of liquid biopsy coupled with low risk entails repeated samples that can be taken whenever necessary to monitor dynamic changes in tumor progression after drugs are started. Liquid biopsy tests generally cost less and take lesser time than the traditional biopsy for sample taking.

Liquid Biopsy has a Tendency to Give Greater False Positives than Traditional Biopsies, Which Could Dampen Potential Revenues

In developing markets, traditional biopsies are still preferred over liquid biopsy. Higher proportion of false positive are estimated to be obtained from liquid biopsy tests. This attribute contributes towards weakened adoption of liquid biopsy procedures in resource constrained settings, where multiple liquid biopsy tests are not feasible and also not possible. False positive result in liquid biopsy can lead to overtreatment which can undermine patient health safety.

Despite Huge Research and Development Expenses Incurred, the Path to Success in Liquid Biopsy Market is Not Clear

Huge research and development expenditures have been incurred in liquid biopsy. Funds above US$ 5 billion have been invested as noted by many competitors in the liquid biopsy market including GRAIL, Guardant Health, Adaptive Biotechnologies, and Biocartis. Deepening financial crisis, austerity and cut down on operating expenses are restraining the flow of further funds into R&D without definitive results in liquid biopsy domain. Resistance to switch from traditional to liquid biopsy and fading adoption rate of liquid biopsy post the initial phase are leading to unstable growth rates in the liquid biopsy market. Marketplace discussions indicate that strong marketing tactics are highly effective only during the initial land-grab phase. Thus the fate of most small companies in the liquid biopsy market is uncertain unless they plan to tie up with some bigger companies.

Strategic Agreements Among Established Players to Increase Penetration in the China Liquid Biopsy Market

In Asia Pacific region, the liquid biopsy market is still in the nascent stage. However, the adoption rate of liquid biopsy tests by the healthcare industry is expected to increase during the forecast period owing to launch of new liquid biopsy products in the region along with entry of new market players through strategic agreements. This is due to increasing prevalence of cancer in the region. Increasing number of established companies in the global liquid biopsy market are entering into strategic agreements with other players in the liquid biopsy market to leverage untapped opportunities in developing regional markets. Janssen Global Services, LLC., received approval from China State Food & Drug Administration (SFDA) for CELLSEARCH circulating tumor cell (CTC) liquid biopsy test to detect breast cancer in China in 2012.  Merck & Co., Inc. entered into an agreement with Xiamen-based Amoy Diagnostics Co., Ltd., for development and commercialization of liquid biopsy RAS biomarker test.

Liquid Biopsy Market is Expected to Consolidate due to Increasing Number of Mergers over the Forecast Period

The companies in the global liquid biopsy market are actively engaged in mergers and acquisitions, as the industry is in its growth phase because of continuous technology upgrade and launch of novel blood tests to detect cancer. The players in the liquid biopsy industry are taking strategic decisions to engage in mergers and acquisitions to strengthen their product portfolio and increase their brand share in the market. With these strategies the companies have made their position in advanced liquid biopsy diagnostic market. For example, Qiagen acquired AdnaGen’s circulating tumor cell (CTC) enrichment technology to boost its capabilities in the liquid biopsy market two years ago.

Note: For detailed analysis on all the key market factors, request a sample.

Competitive Landscape

The FMI report titled “Liquid Biopsy Market” provides detailed information about the growth parameters of the liquid biopsy companies. It includes detailed assessment of the competitive environment in the liquid biopsy market. The market study provides comprehensive data on each stakeholder in the liquid biopsy market, including BIOCEPT, INC., Qiagen N.V., Trovagene, Inc., Janssen Global Services, LLC, MDxHealth SA, Natera, Inc., F. Hoffmann-La Roche Ltd., Silicon Biosystems, Pathway Genomics Corporation, Sysmex Corporation. The liquid biopsy report provides readers with all-encompassing data on each liquid biopsy test manufacturer’s revenue shares, winning strategies, and latest information on mergers and acquisitions in the liquid biopsy market. Inorganic strategies are the primary strategies being considered for revenue growth in the liquid biopsy market. This is due to fragmented nature of the liquid biopsy market coupled with high cost of R&D, expensive marketing efforts required to influence adoption rates and other psychological factors.

Definition

As per the industry, liquid biopsy is a minimally invasive technology to detect disease biomarkers particularly in clinical cancer research and diagnostics. Liquid biopsy method provides sensitive, specific and rapid sample purification, amplification and detection technologies for circulating tumor DNA (ctDNA), RNA from exosomes (exoRNA), and NA from circulating tumor cells (CTCs).

About the Report

The market study on the Liquid Biopsy market was recently published by FMI, which provides comprehensive information about the most important market dynamics that prove instrumental in the growth of the Liquid Biopsy market during 2016-2026. Companies in the Liquid Biopsy Market can find the most accurate quantitative and qualitative information about the growth parameters of the other liquid biopsy test manufacturers, which can help them develop data-driven business strategies in the coming future.

Segmentation

The FMI report on liquid biopsy market provides salient information on market players. The liquid biopsy market is segmented by region, by marker type, sample type, disease indication, end users, to analyze the segment-wise growth of the liquid biopsy market. Based on region, the liquid biopsy market is segmented into seven regions – North America, Latin America, Western Europe, Eastern Europe, Japan, Asia Pacific Excluding Japan (APEJ), and the Middle East & Africa (MEA). The liquid biopsy market is segmented into biomarker types, viz., CTCs (Circulating tumour Cells), ctNA (Circulating tumour  Nucleic Acids) and Exosomes. Depending on the sample type, the liquid biopsy market is divided into blood, urine, others. By end user type, the liquid biopsy market is segmented into hospitals, cancer institutes, academic institutes, diagnostic centres. By disease application, the liquid biopsy market is divided into lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, colorectal cancer, leukemia and others. Case studies on liquid biopsy have also been included in the report.

global liquid biopsy market

Additional Questions Answered

Readers can find detailed information about the important positive and negative factors affecting Liquid Biopsy market during the forecast period. Additionally, the Liquid Biopsy market report also contains valuable information that can provide liquid biopsy market players with answers to critical questions, such as

  • Which types of biomarkers and sample types account for the maximum demand for Liquid Biopsy market? Why is it so?

  • Why are the sales of Liquid Biopsy services and products highest in North America?

  • Which regulations in various regional segments are influencing the strategies of players in the Liquid Biopsy market?

  • Why is APEJ currently attracting lots of traction among most of the leading liquid biopsy market players?

  • What are the current technology trends adopted by various Liquid Biopsy companies?

Research Methodology

The process of market research followed at FMI commences with extensive secondary research of the Liquid Biopsy market. Analysts obtain industry-validated, historic, and current data about the demand for Liquid Biopsy across the globe. Comprehensive secondary research is followed by extensive and in-depth primary research, where detailed information about the Liquid Biopsy market is obtained in terms of value (US$ Million). Based on thorough secondary and primary research of the growth parameters of the Liquid Biopsy market, analysts come up with the most precise forecast on how the Liquid Biopsy market will grow during the forecast period.

Note: Request methodology.

Liquid Biopsy Market: Accuracy in detection and minimally invasive nature of liquid biopsy testing fuelling revenue growth

A recent market study published by FMI – “Liquid Biopsy Market: Global Industry Analysis and Opportunity Assessment 2016 – 2026” consists a comprehensive assessment of the most important market dynamics. On conducting a thorough research on the historic as well as current growth parameters of the liquid biopsy market, growth prospects of the market are obtained with maximum precision. The report features unique and salient factors impacting development of the liquid biopsy market during the forecast period. It can help liquid biopsy manufacturers to modify their manufacturing and marketing strategies to envisage maximum growth. The liquid biopsy market report provides detailed information about the current and future growth prospects of the liquid biopsy market in the most comprehensive way for stakeholders.

Chapter 1 – Executive Summary

The report commences with the executive summary of the liquid biopsy market report, which includes the summary of key findings and statistics. It also includes the market value (US$ million) estimates for leading segments of the liquid biopsy market and differentiating strategies applied by leading liquid biopsy market players.

Chapter 2– Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 3 – Research Methodology

This chapter helps readers to understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the liquid biopsy market. Liquid biopsy have been tracked by test manufacturers’ market share by revenues in total market. Prevalence of cancer, liquid biopsy adoption rates (both primary and secondary) by region, product penetration, etc. parameters have been considered to value liquid biopsy market. Further, data on pricing has been analyzed separately to arrive at correct value of the total market. Market value validation has been done through interviews with key stakeholders in liquid biopsy market. 

Chapter 4 – Liquid Biopsy Market Overview

This section of liquid biopsy market report has two parts. The first section includes detailed taxonomy and the definition of the liquid biopsy market related products. The liquid biopsy market has been segmented by regions, marker type, sample type, disease applications and end user channels.

This next chapter includes the analysis of the key drivers, challenges, trends, and opportunities of liquid biopsy market. A global overview for liquid biopsy products, reimbursement analysis, pipeline assessment by liquid biopsy products, liquid biopsy product penetration and pricing impact, revenue potential of liquid biopsy, regulation for product approvals, and case studies on liquid biopsy have been included here. This is expected to help readers to get introduced to the important factors complementing the growth of the liquid biopsy market.

This chapter provides details regarding the macroeconomic assumptions taken in order to set the scenario affecting liquid biopsy market being adopted in leading countries. This is expected to give a clear understanding on liquid biopsy market value derivation.

Chapter 5 – Global Liquid Biopsy Market Forecast

This chapter includes y-o-y growth projection, absolute dollar opportunities and overall market snapshot for liquid biopsy market segments – marker, sample, disease indication, end user and region types.

Chapter 6 – Global Liquid Biopsy Market Analysis 2016-2026, By Sample Type

Based on the sample type, the liquid biopsy market is segmented into blood, urine, others (plasma, saliva, CSF). In this chapter, readers can find information about key trends and developments in the liquid biopsy market and market attractive analysis based on sample type.

Chapter 7 – Global Liquid Biopsy Market Analysis 2016-2026, By Marker Type

The liquid biopsy market is segmented on the basis of diseases requiring liquid biopsy – into CTCs (circulating tumor cells), ctIndication (circulating tumor nucleic acids) and exosomes. This chapter includes detailed information on demand-supply analysis of liquid biopsy treatments depending on its marker type.

Chapter 8 – Global Liquid Biopsy Market Analysis 2016-2026, By End User

By End User, the liquid biopsy market is segmented into hospitals, cancer institutes, academic institutes, and diagnostic centers.

Chapter 9 – Global Liquid Biopsy Market Analysis 2016-2026, By Disease Indication

By Disease Indication, the liquid biopsy market is segmented into lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, colorectal cancer, leukemia and others. Case studies on liquid biopsy have also been included in the report.

Chapter 10 – Global Liquid Biopsy Market Analysis 2016-2026, By Region

This chapter explains how the liquid biopsy market will grow across various geographic regions, such as North America, Latin America, Western Europe, Eastern Europe, Japan, Asia-Pacific Excluding Japan (APEJ), and the Middle East & Africa (MEA).

Chapter 11 – North America Liquid Biopsy Market Analysis 2016-2026

This chapter includes detailed analysis of the growth of the North America liquid biopsy market along with the country-wise assessment including the U.S. and Canada. Readers can also find regional trends, regulations, and market growth based on marker, sample, disease indication, end user types of Liquid Biopsy. Impact analysis on dynamics for liquid biopsy is also provided with key presence of leading players in North America region

Chapter 12 – Latin America Liquid Biopsy Market Analysis 2016-2026

Readers can find detailed information about factors such as key regulations, and regional trends that are impacting the growth of the Latin America liquid biopsy market. This chapter also includes the growth prospects of the liquid biopsy market in leading LatAm countries such as Argentina, Brazil, Mexico, and rest of the Latin American region based on marker, sample, disease indication, end user type of Liquid Biopsy. Impact analysis on dynamics for liquid biopsy is also provided with key presence of leading players in Latin America region

Chapter 13 – Western Europe Liquid Biopsy Market Analysis 2016-2026

Important growth prospects of the liquid biopsy market based on marker, sample, disease indication, end user type is provided for countries, such as Germany, UK, Italy, Spain, France, BENELUX, NORDIC, and in Rest of Western Europe. This also includes key regional trends and factors shaping the growth of the liquid biopsy market. Impact analysis on dynamics for liquid biopsy is also provided with key presence of leading players in Western Europe region

Chapter 14 – Eastern Europe Liquid Biopsy Market Analysis 2016-2026    

This chapter includes key growth prospects of the liquid biopsy market based on marker, sample, disease indication, end user - in several Eastern European countries, such as Russia, Poland and in Rest of Eastern Europe. This also includes key regional trends and factors shaping the growth of the liquid biopsy market with immediate effect. Impact analysis on dynamics for liquid biopsy is also provided with key presence of leading players in Eastern Europe region

Chapter 15- Asia Pacific Excluding Japan Liquid Biopsy Market Analysis 2016-2026

Readers can find detailed information about revenue growth promoting factors such as key regulations, and regional trends that are impacting the regional liquid biopsy market. This chapter also includes the growth prospects of the liquid biopsy market in leading countries such as Australia & New Zealand, India, ASEAN, Greater China and rest of APEJ. This region is currently witnessing very high adoption of liquid biopsy treatments and is expected to remain sustainably profitable.

Chapter 16- Japan Liquid Biopsy Market Analysis 2016-2026

This chapter includes the revenue growth and forecast in the Japan liquid biopsy Market which is segmented into marker, sample, disease indication, end user type. Also includes key factors and trends affecting the Japan liquid biopsy market.

Chapter 17 – MEA Liquid Biopsy Market Analysis 2016-2026

This chapter provides information on how the liquid biopsy market will grow in the major countries in MEA region, such as GCC Countries, South Africa and rest of MEA during the period 2016-2026.

Chapter 18 – Competition Landscape

In this chapter, the report provides detailed information about growth parameters of the liquid biopsy market with the help of a detailed assessment of the competitive environment in the liquid biopsy market. The market study provides a comprehensive data on each stakeholder in the liquid biopsy market, including BIOCEPT, INC., Qiagen N.V., Trovagene, Inc., Janssen Global Services, LLC, MDxHealth SA, Natera, Inc., F. Hoffmann-La Roche Ltd., Silicon Biosystems, Pathway Genomics Corporation, Sysmex Corporation and more. The report provides readers with all-encompassing data on each manufacturer’s revenue shares, winning strategies, and latest information on mergers and acquisitions in the liquid biopsy market.

Liquid Biopsy Market 112017 Reports - Table of Contents

  1. Executive Summary

    • Overview

    • Market Analysis

    • FMI Analysis and Recommendations

  2. Market Introduction

    • Market Taxonomy

    • Market Definition

  3. Liquid Biopsy Market View Point Analysis 

    • Macro-Economic Factors

    • Opportunity Analysis

    • Demand Side Drives

    • Supply Side Drivers

    • Restraints

    • Trends

    • Epidemiology Assessment

    • Reimbursement Scenario

    • Pipeline Assessment

    • Strategies and Price Impact

    • Case Study

  4. North America Liquid Biopsy Market Analysis 2012–2016 and Forecast 2017–2027

    • Introduction

    • Regional Market Trends

    • Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

      • U.S.

      • Canada

    • Market Size (US$ Mn) Forecast By Country, 2017–2027

      • U.S.

      • Canada

    • Historical Market Size (US$ Mn) Trend Analysis By Biomarker Type, 2012–2016

      • CTC (Circulating Tumor Cells)

      • ctNA (Circulating Tumor Nucliec Acids)

      • Exosomes 

    • Market Size (US$ Mn) Forecast By Biomarker Type, 2017–2027

      • CTC (Circulating Tumor Cells)

      • ctNA (Circulating Tumor Nucliec Acids)

      • Exosomes 

    • Historical Market Size (US$ Mn) Trend Analysis By Sample Type, 2012–2016

      • Blood

      • Urine

      • Others

    • Market Size (US$ Mn) Forecast By Sample Type, 2017–2027

      • Blood

      • Urine

      • Others

    • Historical Market Size (US$ Mn) Trend Analysis By Disease Indication, 2012–2016

      • Lung Cancer

      • Gastrointestinal Cancer

      • Prostate Cancer

      • Breast Cancer

      • Colorectal Cancer

      • Leukemia

      • Others

    • Market Size (US$ Mn) Forecast By Disease Indication, 2017–2027

      • Lung Cancer

      • Gastrointestinal Cancer

      • Prostate Cancer

      • Breast Cancer

      • Colorectal Cancer

      • Leukemia

      • Others

    • Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

      • Hospitals

      • Cancer Institutes

      • Academic Institutes

      • Diagnostic Centers 

    • Market Size (US$ Mn) Forecast By End User, 2017–2027

      • Hospitals

      • Cancer Institutes

      • Academic Institutes

      • Diagnostic Centers 

    • Drivers and Restraints: Impact Analysis

    • Market Attractiveness Analysis

      • By Country

      • By Biomarker Type  

      • By Sample Type  

      • By Disease Indication

      • By End User

  5. Latin America Liquid Biopsy Market Analysis 2012–2016 and Forecast 2017–2027

    • Introduction

    • Regional Market Trends

    • Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

      • Brazil

      • Mexico

      • Rest of Latin America

    • Market Size (US$ Mn) Forecast By Country, 2017–2027

      • Brazil

      • Mexico

      • Rest of Latin America

    • Historical Market Size (US$ Mn) Trend Analysis By Biomarker Type, 2012–2016

      • CTC (Circulating Tumor Cells)

      • ctNA (Circulating Tumor Nucliec Acids)

      • Exosomes 

    • Market Size (US$ Mn) Forecast By Biomarker Type, 2017–2027

      • CTC (Circulating Tumor Cells)

      • ctNA (Circulating Tumor Nucliec Acids)

      • Exosomes 

    • Historical Market Size (US$ Mn) Trend Analysis By Sample Type, 2012–2016

      • Blood

      • Urine

      • Others

    • Market Size (US$ Mn) Forecast By Sample Type, 2017–2027

      • Blood

      • Urine

      • Others

    • Historical Market Size (US$ Mn) Trend Analysis By Disease Indication, 2012–2016

      • Lung Cancer

      • Gastrointestinal Cancer

      • Prostate Cancer

      • Breast Cancer

      • Colorectal Cancer

      • Leukemia

      • Others

    • Market Size (US$ Mn) Forecast By Disease Indication, 2017–2027

      • Lung Cancer

      • Gastrointestinal Cancer

      • Prostate Cancer

      • Breast Cancer

      • Colorectal Cancer

      • Leukemia

      • Others

    • Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

      • Hospitals

      • Cancer Institutes

      • Academic Institutes

      • Diagnostic Centers 

    • Market Size (US$ Mn) Forecast By End User, 2017–2027

      • Hospitals

      • Cancer Institutes

      • Academic Institutes

      • Diagnostic Centers 

    • Drivers and Restraints: Impact Analysis

    • Market Attractiveness Analysis

      • By Country

      • By Biomarker Type  

      • By Sample Type  

      • By Disease Indication

      • By End User

  6. Western Europe Liquid Biopsy Market Analysis 2012–2016 and Forecast 2017–2027

    • Introduction

    • Regional Market Trends

    • Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

      • U.K.

      • Germany

      • France

      • Spain

      • Italy

      • NORDIC

      • BENELUX

      • Rest of Western Europe

    • Market Size (US$ Mn) Forecast By Country, 2017–2027

      • U.K.

      • Germany

      • France

      • Spain

      • Italy

      • NORDIC

      • BENELUX

      • Rest of Western Europe

    • Historical Market Size (US$ Mn) Trend Analysis By Biomarker Type, 2012–2016

      • CTC (Circulating Tumor Cells)

      • ctNA (Circulating Tumor Nucliec Acids)

      • Exosomes 

    • Market Size (US$ Mn) Forecast By Biomarker Type, 2017–2027

      • CTC (Circulating Tumor Cells)

      • ctNA (Circulating Tumor Nucliec Acids)

      • Exosomes 

    • Historical Market Size (US$ Mn) Trend Analysis By Sample Type, 2012–2016

      • Blood

      • Urine

      • Others

    • Market Size (US$ Mn) Forecast By Sample Type, 2017–2027

      • Blood

      • Urine

      • Others

    • Historical Market Size (US$ Mn) Trend Analysis By Disease Indication, 2012–2016

      • Lung Cancer

      • Gastrointestinal Cancer

      • Prostate Cancer

      • Breast Cancer

      • Colorectal Cancer

      • Leukemia

      • Others

    • Market Size (US$ Mn) Forecast By Disease Indication, 2017–2027

      • Lung Cancer

      • Gastrointestinal Cancer

      • Prostate Cancer

      • Breast Cancer

      • Colorectal Cancer

      • Leukemia

      • Others

    • Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

      • Hospitals

      • Cancer Institutes

      • Academic Institutes

      • Diagnostic Centers 

    • Market Size (US$ Mn) Forecast By End User, 2017–2027

      • Hospitals

      • Cancer Institutes

      • Academic Institutes

      • Diagnostic Centers 

    • Drivers and Restraints: Impact Analysis

    • Market Attractiveness Analysis

      • By Country

      • By Biomarker Type  

      • By Sample Type  

      • By Disease Indication

      • By End User

  7. Eastern Europe Liquid Biopsy Market Analysis 2012–2016 and Forecast 2017–2027

    • Introduction

    • Regional Market Trends

    • Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

      • Russia

      • Poland

      • Rest of Eastern Europe

    • Market Size (US$ Mn) Forecast By Country, 2017–2027

      • Russia

      • Poland

      • Rest of Eastern Europe

    • Historical Market Size (US$ Mn) Trend Analysis By Biomarker Type, 2012–2016

      • CTC (Circulating Tumor Cells)

      • ctNA (Circulating Tumor Nucliec Acids)

      • Exosomes 

    • Market Size (US$ Mn) Forecast By Biomarker Type, 2017–2027

      • CTC (Circulating Tumor Cells)

      • ctNA (Circulating Tumor Nucliec Acids)

      • Exosomes 

    • Historical Market Size (US$ Mn) Trend Analysis By Sample Type, 2012–2016

      • Blood

      • Urine

      • Others

    • Market Size (US$ Mn) Forecast By Sample Type, 2017–2027

      • Blood

      • Urine

      • Others

    • Historical Market Size (US$ Mn) Trend Analysis By Disease Indication, 2012–2016

      • Lung Cancer

      • Gastrointestinal Cancer

      • Prostate Cancer

      • Breast Cancer

      • Colorectal Cancer

      • Leukemia

      • Others

    • Market Size (US$ Mn) Forecast By Disease Indication, 2017–2027

      • Lung Cancer

      • Gastrointestinal Cancer

      • Prostate Cancer

      • Breast Cancer

      • Colorectal Cancer

      • Leukemia

      • Others

    • Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

      • Hospitals

      • Cancer Institutes

      • Academic Institutes

      • Diagnostic Centers 

    • Market Size (US$ Mn) Forecast By End User, 2017–2027

      • Hospitals

      • Cancer Institutes

      • Academic Institutes

      • Diagnostic Centers 

    • Drivers and Restraints: Impact Analysis

    • Market Attractiveness Analysis

      • By Country

      • By Biomarker Type  

      • By Sample Type  

      • By Disease Indication

      • By End User

  8. Asia Pacific excluding Japan Liquid Biopsy Market Analysis 2012–2016 and Forecast 2017–2027

    • Introduction

    • Regional Market Trends

    • Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

      • China

      • India

      • Australia and New Zealand

      • ASEAN

      • Rest of APEJ

    • Market Size (US$ Mn) Forecast By Country, 2017–2027

      • China

      • India

      • Australia and New Zealand

      • ASEAN

      • Rest of APEJ

    • Historical Market Size (US$ Mn) Trend Analysis By Biomarker Type, 2012–2016

      • CTC (Circulating Tumor Cells)

      • ctNA (Circulating Tumor Nucliec Acids)

      • Exosomes 

    • Market Size (US$ Mn) Forecast By Biomarker Type, 2017–2027

      • CTC (Circulating Tumor Cells)

      • ctNA (Circulating Tumor Nucliec Acids)

      • Exosomes 

    • Historical Market Size (US$ Mn) Trend Analysis By Sample Type, 2012–2016

      • Blood

      • Urine

      • Others

    • Market Size (US$ Mn) Forecast By Sample Type, 2017–2027

      • Blood

      • Urine

      • Others

    • Historical Market Size (US$ Mn) Trend Analysis By Disease Indication, 2012–2016

      • Lung Cancer

      • Gastrointestinal Cancer

      • Prostate Cancer

      • Breast Cancer

      • Colorectal Cancer

      • Leukemia

      • Others

    • Market Size (US$ Mn) Forecast By Disease Indication, 2017–2027

      • Lung Cancer

      • Gastrointestinal Cancer

      • Prostate Cancer

      • Breast Cancer

      • Colorectal Cancer

      • Leukemia

      • Others

    • Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

      • Hospitals

      • Cancer Institutes

      • Academic Institutes

      • Diagnostic Centers 

    • Market Size (US$ Mn) Forecast By End User, 2017–2027

      • Hospitals

      • Cancer Institutes

      • Academic Institutes

      • Diagnostic Centers 

    • Drivers and Restraints: Impact Analysis

    • Market Attractiveness Analysis

      • By Country

      • By Biomarker Type  

      • By Sample Type  

      • By Disease Indication

      • By End User

  9. Japan Liquid Biopsy Market Analysis 2012–2016 and Forecast 2017–2027

    • Introduction

    • Regional Market Trends

    • Historical Market Size (US$ Mn) Trend Analysis By Biomarker Type, 2012–2016

      • CTC (Circulating Tumor Cells)

      • ctNA (Circulating Tumor Nucliec Acids)

      • Exosomes 

    • Market Size (US$ Mn) Forecast By Biomarker Type, 2017–2027

      • CTC (Circulating Tumor Cells)

      • ctNA (Circulating Tumor Nucliec Acids)

      • Exosomes 

    • Historical Market Size (US$ Mn) Trend Analysis By Sample Type, 2012–2016

      • Blood

      • Urine

      • Others

    • Market Size (US$ Mn) Forecast By Sample Type, 2017–2027

      • Blood

      • Urine

      • Others

    • Historical Market Size (US$ Mn) Trend Analysis By Disease Indication, 2012–2016

      • Lung Cancer

      • Gastrointestinal Cancer

      • Prostate Cancer

      • Breast Cancer

      • Colorectal Cancer

      • Leukemia

      • Others

    • Market Size (US$ Mn) Forecast By Disease Indication, 2017–2027

      • Lung Cancer

      • Gastrointestinal Cancer

      • Prostate Cancer

      • Breast Cancer

      • Colorectal Cancer

      • Leukemia

      • Others

    • Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

      • Hospitals

      • Cancer Institutes

      • Academic Institutes

      • Diagnostic Centers 

    • Market Size (US$ Mn) Forecast By End User, 2017–2027

      • Hospitals

      • Cancer Institutes

      • Academic Institutes

      • Diagnostic Centers 

    • Drivers and Restraints: Impact Analysis

    • Market Attractiveness Analysis

      • By Biomarker Type  

      • By Sample Type  

      • By Disease Indication

      • By End User

  10. Middle East & Africa Liquid Biopsy Market Analysis 2012–2016 and Forecast 2017–2027

    • Introduction

    • Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

      • GCC Countries

      • South Africa

      • Rest of MEA

    • Market Size (US$ Mn) Forecast By Country, 2017–2027

      • GCC Countries

      • South Africa

      • Rest of MEA

    • Historical Market Size (US$ Mn) Trend Analysis By Biomarker Type, 2012–2016

      • CTC (Circulating Tumor Cells)

      • ctNA (Circulating Tumor Nucliec Acids)

      • Exosomes 

    • Market Size (US$ Mn) Forecast By Biomarker Type, 2017–2027

      • CTC (Circulating Tumor Cells)

      • ctNA (Circulating Tumor Nucliec Acids)

      • Exosomes 

    • Historical Market Size (US$ Mn) Trend Analysis By Sample Type, 2012–2016

      • Blood

      • Urine

      • Others

    • Market Size (US$ Mn) Forecast By Sample Type, 2017–2027

      • Blood

      • Urine

      • Others

    • Historical Market Size (US$ Mn) Trend Analysis By Disease Indication, 2012–2016

      • Lung Cancer

      • Gastrointestinal Cancer

      • Prostate Cancer

      • Breast Cancer

      • Colorectal Cancer

      • Leukemia

      • Others

    • Market Size (US$ Mn) Forecast By Disease Indication, 2017–2027

      • Lung Cancer

      • Gastrointestinal Cancer

      • Prostate Cancer

      • Breast Cancer

      • Colorectal Cancer

      • Leukemia

      • Others

    • Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

      • Hospitals

      • Cancer Institutes

      • Academic Institutes

      • Diagnostic Centers 

    • Market Size (US$ Mn) Forecast By End User, 2017–2027

      • Hospitals

      • Cancer Institutes

      • Academic Institutes

      • Diagnostic Centers 

    • Drivers and Restraints: Impact Analysis

    • Market Attractiveness Analysis

      • By Country

      • By Biomarker Type  

      • By Sample Type  

      • By Disease Indication

      • By End User

  11. Competition Landscape

    • Competition Dashboard

    • Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)

      • Biocept, Inc.

      • Qiagen N.V.

      • Trovagene, Inc.

      • Johnson & Johnson

      • MDxHealth SA

      • Natera, Inc.

      • Hoffman-La Roche Ltd.

      • Silicon Biosystems S.p.A.

      • Pathway Genomics Corporation

      • Sysmex Corporation

  12. Global Liquid Biopsy Market Analysis 2012–2016 and Forecast 2017–2027, By Region

    • Introduction/Key Findings

    • Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016

      • North America

      • Latin America

      • Western Europe

      • Eastern Europe

      • Asia Pacific excluding Japan

      • Japan 

      • Middle East & Africa

    • Market Size (US$ Mn) Forecast By Region, 2017–2027

      • North America

      • Latin America

      • Western Europe

      • Eastern Europe

      • Asia Pacific excluding Japan

      • Japan 

      • Middle East & Africa

    • Market Attractiveness Analysis By Region

  13. Global Pain Therapeutic Solutions Market Analysis 2012–2016 and Forecast 2017–2027, By Biomarker Type  

    • Introduction/Key Findings

    • Historical Market Size (US$ Mn) Trend Analysis By Biomarker Type, 2012–2016

      • CTC (Circulating Tumor Cells)

      • ctNA (Circulating Tumor Nucliec Acids)

      • Exosomes

    • Market Size (US$ Mn) Forecast By Biomarker Type, 2017–2027

      • CTC (Circulating Tumor Cells)

      • ctNA (Circulating Tumor Nucliec Acids)

      • Exosomes

    • Market Attractiveness Analysis By Biomarker Type  

  14. Global Liquid Biopsy Market Analysis 2012–2016 and Forecast 2017–2027, By Sample Type  

    • Introduction/Key Findings

    • Historical Market Size (US$ Mn) Trend Analysis By Sample Type, 2012–2016

      • Blood

      • Urine

      • Others

    • Market Size (US$ Mn) Forecast By Sample Type  , 2017–2027

      • Blood

      • Urine

      • Others

    • Market Attractiveness Analysis By Sample Type  

  15. Global Liquid Biopsy Market Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

    • Introduction/Key Findings

    • Historical Market Size (US$ Mn) Trend Analysis By Disease Indication, 2012–2016

      • Lung Cancer

      • Gastrointestinal Cancer

      • Prostate Cancer

      • Breast Cancer

      • Colorectal Cancer

      • Leukemia

      • Others

    • Market Size (US$ Mn) Forecast By Disease Indication, 2017–2027

      • Lung Cancer

      • Gastrointestinal Cancer

      • Prostate Cancer

      • Breast Cancer

      • Colorectal Cancer

      • Leukemia

      • Others

    • Market Attractiveness Analysis By Disease Indication

  16. Global Liquid Biopsy Market Analysis 2012–2016 and Forecast 2017–2027, By End User

    • Introduction/Key Findings

    • Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

      • Hospitals

      • Cancer Institutes

      • Academic Institutes

      • Diagnostic Centers

    • Market Size (US$ Mn) Forecast By End User, 2017–2027

      • Hospitals

      • Cancer Institutes

      • Academic Institutes

      • Diagnostic Centers

    • Market Attractiveness Analysis By End User

  17. Global Liquid Biopsy Market Analysis 2012–2016 and Forecast 2017–2027

    • Market Size and Y-o-Y Growth

    • Absolute $ Opportunity

  18. Assumptions and Acronyms Used

  19. Research Methodology

Liquid Biopsy Market 112017 Reports - List of Tables

  1. North America Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Country

  2. North America Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Biomarker Type

  3. North America Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Sample Type

  4. North America Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

  5. North America Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By End User

  6. Latin America Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Country

  7. Latin America Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Biomarker Type

  8. Latin America Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Sample Type

  9. Latin America Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

  10. Latin America Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By End User

  11. Western Europe Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Country

  12. Western Europe Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Biomarker Type

  13. Western Europe Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Sample Type

  14. Western Europe Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

  15. Western Europe Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By End User

  16. Eastern Europe Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Country

  17. Eastern Europe Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Biomarker Type

  18. Eastern Europe Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Sample Type

  19. Eastern Europe Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

  20. Eastern Europe Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By End User

  21. APEJ Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Country

  22. APEJ Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Biomarker Type

  23. APEJ Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Sample Type

  24. APEJ Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

  25. APEJ Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By End User

  26. Japan Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Biomarker Type

  27. Japan Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Sample Type

  28. Japan Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

  29. Japan Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By End User

  30. MEA Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Country

  31. MEA Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Biomarker Type

  32. MEA Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Sample Type

  33. MEA Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

  34. MEA Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By End User

  35. Global Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Region

  36. Global Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Biomarker Type

  37. Global Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Sample Type

  38. Global Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

  39. Global Liquid Biopsy Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By End User

Liquid Biopsy Market 112017 Reports - List of Figures

  1. Global Liquid Biopsy Market Value Share By Biomarker Type (2016A)

  2. Global Liquid Biopsy Market Value Share By Sample Type (2016A)

  3. Global Liquid Biopsy Market Value Share By Disease Indication (2016A)

  4. Global Liquid Biopsy Market Value Share By End User (2016A)

  5. Global Liquid Biopsy Market Value Share By Region (2016A)

  6. North America Liquid Biopsy Market Value Share By Biomarker Type (2017E)

  7. North America Liquid Biopsy Market Value Share By Sample Type (2017E)

  8. North America Liquid Biopsy Market Value Share By Disease Indication (2017E)

  9. North America Liquid Biopsy Market Value Share By End User (2017E)

  10. North America Liquid Biopsy Market Value Share By Region (2017E)

  11. North America Liquid Biopsy Market Size Analysis, 2012-2016

  12. North America Liquid Biopsy Market Forecast, 2017–2027

  13. U.S. Liquid Biopsy Market Size (US$ Mn) Analysis, 2012–2016

  14. U.S. Liquid Biopsy Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027

  15. Canada Liquid Biopsy Market Size (US$ Mn) Analysis, 2012–2016

  16. Canada Liquid Biopsy Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027

  17. North America Liquid Biopsy Market Attractiveness Analysis, By Biomarker Type, 2017–2027 

  18. North America Liquid Biopsy Market Attractiveness Analysis, By Sample Type, 2017–2027 

  19. North America Liquid Biopsy Market Attractiveness Analysis, By End User, 2017–2027 

  20. North America Liquid Biopsy Market Attractiveness Analysis, By Disease Indication, 2017–2027 

  21. North America Liquid Biopsy Market Attractiveness Analysis, By Region, 2017–2027 

  22. Latin America Liquid Biopsy Market Value Share By Biomarker Type (2017E)

  23. Latin America Liquid Biopsy Market Value Share By Sample Type (2017E)

  24. Latin America Liquid Biopsy Market Value Share By Disease Indication (2017E)

  25. Latin America Liquid Biopsy Market Value Share By End User (2017E)

  26. Latin America Liquid Biopsy Market Value Share By Region (2017E)

  27. Latin America Liquid Biopsy Market Size Analysis, 2012-2016

  28. Latin America Liquid Biopsy Market Forecast, 2017–2027

  29. Brazil Liquid Biopsy Market Size (US$ Mn) Analysis, 2012–2016

  30. Brazil Liquid Biopsy Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027

  31. Mexico Liquid Biopsy Market Size (US$ Mn) Analysis, 2012–2016

  32. Mexico Liquid Biopsy Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027

  33. Rest of Latin America Liquid Biopsy Market Size (US$ Mn) Analysis, 2012–2016

  34. Rest of Latin America Liquid Biopsy Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027

  35. Latin America Liquid Biopsy Market Attractiveness Analysis, By Biomarker Type, 2017–2027 

  36. Latin America Liquid Biopsy Market Attractiveness Analysis, By Sample Type, 2017–2027 

  37. Latin America Liquid Biopsy Market Attractiveness Analysis, By End User, 2017–2027 

  38. Latin America Liquid Biopsy Market Attractiveness Analysis, By Disease Indication, 2017–2027 

  39. Latin America Liquid Biopsy Market Attractiveness Analysis, By Region, 2017–2027 

  40. Western Europe Liquid Biopsy Market Value Share By Biomarker Type (2017E)

  41. Western Europe Liquid Biopsy Market Value Share By Sample Type (2017E)

  42. Western Europe Liquid Biopsy Market Value Share By Disease Indication (2017E)

  43. Western Europe Liquid Biopsy Market Value Share By End User (2017E)

  44. Western Europe Liquid Biopsy Market Value Share By Region (2017E)

  45. Western Europe Liquid Biopsy Market Size Analysis, 2012-2016

  46. Western Europe Liquid Biopsy Market Forecast, 2017–2027

  47. U.K. Liquid Biopsy Market Size (US$ Mn) Analysis, 2012–2016 

  48. U.K. Liquid Biopsy Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027

  49. Germany Liquid Biopsy Market Size (US$ Mn) Analysis, 2012–2016

  50. Germany Liquid Biopsy Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027

  51. France Liquid Biopsy Market Size (US$ Mn) Analysis, 2012–2016

  52. France Liquid Biopsy Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027

  53. Spain Liquid Biopsy Market Size (US$ Mn) Analysis, 2012–2016

  54. Spain Liquid Biopsy Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027

  55. Italy Liquid Biopsy Market Size (US$ Mn) Analysis, 2012–2016

  56. Italy Liquid Biopsy Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027

  57. Nordic Liquid Biopsy Market Size (US$ Mn) Analysis, 2012–2016

  58. Nordic Liquid Biopsy Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027

  59. BENELUX Liquid Biopsy Market Size (US$ Mn) Analysis, 2012–2016

  60. BENELUX Liquid Biopsy Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027

  61. Rest of Western Europe Liquid Biopsy Market Size (US$ Mn) Analysis, 2012–2016

  62. Rest of Western Europe Liquid Biopsy Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027

  63. Western Europe Liquid Biopsy Market Attractiveness Analysis, By Biomarker Type, 2017–2027 

  64. Western Europe Liquid Biopsy Market Attractiveness Analysis, By Sample Type, 2017–2027 

  65. Western Europe Liquid Biopsy Market Attractiveness Analysis, By End User, 2017–2027 

  66. Western Europe Liquid Biopsy Market Attractiveness Analysis, By Disease Indication, 2017–2027 

  67. Western Europe Liquid Biopsy Market Attractiveness Analysis, By Region, 2017–2027 

  68. Eastern Europe Liquid Biopsy Market Value Share By Biomarker Type (2017E)

  69. Eastern Europe Liquid Biopsy Market Value Share By Sample Type (2017E)

  70. Eastern Europe Liquid Biopsy Market Value Share By Disease Indication (2017E)

  71. Eastern Europe Liquid Biopsy Market Value Share By End User (2017E)

  72. Eastern Europe Liquid Biopsy Market Value Share By Region (2017E)

  73. Eastern Europe Liquid Biopsy Market Size Analysis, 2012-2016

  74. Eastern Europe Liquid Biopsy Market Forecast, 2017–2027

  75. Russia Liquid Biopsy Market Size (US$ Mn) Analysis, 2012–2016

  76. Russia Liquid Biopsy Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027

  77. Poland Liquid Biopsy Market Size (US$ Mn) Analysis, 2012–2016

  78. Poland Liquid Biopsy Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027

  79. Rest of Eastern Europe Liquid Biopsy Market Size (US$ Mn) Analysis, 2012–2016

  80. Rest of Eastern Europe Liquid Biopsy Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027

  81. Eastern Europe Liquid Biopsy Market Attractiveness Analysis, By Biomarker Type, 2017–2027 

  82. Eastern Europe Liquid Biopsy Market Attractiveness Analysis, By Sample Type, 2017–2027 

  83. Eastern Europe Liquid Biopsy Market Attractiveness Analysis, By End User, 2017–2027 

  84. Eastern Europe Liquid Biopsy Market Attractiveness Analysis, By Disease Indication, 2017–2027 

  85. Eastern Europe Liquid Biopsy Market Attractiveness Analysis, By Region, 2017–2027 

  86. APEJ Liquid Biopsy Market Value Share By Biomarker Type (2017E)

  87. APEJ Liquid Biopsy Market Value Share By Sample Type (2017E)

  88. APEJ Liquid Biopsy Market Value Share By Disease Indication (2017E)

  89. APEJ Liquid Biopsy Market Value Share By End User (2017E)

  90. APEJ Liquid Biopsy Market Value Share By Region (2017E)

  91. APEJ Liquid Biopsy Market Size Analysis, 2012-2016

  92. APEJ Liquid Biopsy Market Forecast, 2017–2027

  93. China Liquid Biopsy Market Size (US$ Mn) Analysis, 2012–2016

  94. China Liquid Biopsy Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027

  95. India Liquid Biopsy Market Size (US$ Mn) Analysis, 2012–2016

  96. India Liquid Biopsy Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027

  97. Australia & New Zealand Liquid Biopsy Market Size (US$ Mn) Analysis, 2012–2016

  98. Australia & New Zealand Liquid Biopsy Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027

  99. ASEAN Liquid Biopsy Market Size (US$ Mn) Analysis, 2012–2016

  100. ASEAN Liquid Biopsy Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027

  101. Rest of APEJ Liquid Biopsy Market Size (US$ Mn) Analysis, 2012–2016

  102. Rest of APEJ Liquid Biopsy Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027

  103. APEJ Liquid Biopsy Market Attractiveness Analysis, By Biomarker Type, 2017–2027 

  104. APEJ Liquid Biopsy Market Attractiveness Analysis, By Sample Type, 2017–2027 

  105. APEJ Liquid Biopsy Market Attractiveness Analysis, By End User, 2017–2027 

  106. APEJ Liquid Biopsy Market Attractiveness Analysis, By Disease Indication, 2017–2027 

  107. APEJ Liquid Biopsy Market Attractiveness Analysis, By Region, 2017–2027 

  108. Japan Liquid Biopsy Market Value Share By Biomarker Type (2017E)

  109. Japan Liquid Biopsy Market Value Share By Sample Type (2017E)

  110. Japan Liquid Biopsy Market Value Share By Disease Indication (2017E)

  111. Japan Liquid Biopsy Market Value Share By End User (2017E)

  112. Japan Liquid Biopsy Market Size Analysis, 2012-2016

  113. Japan Liquid Biopsy Market Forecast, 2017–2027

  114. Japan Liquid Biopsy Market Attractiveness Analysis, By Biomarker Type, 2017–2027 

  115. Japan Liquid Biopsy Market Attractiveness Analysis, By Sample Type, 2017–2027 

  116. Japan Liquid Biopsy Market Attractiveness Analysis, By End User, 2017–2027 

  117. Japan Liquid Biopsy Market Attractiveness Analysis, By Disease Indication, 2017–2027 

  118. MEA Liquid Biopsy Market Value Share By Biomarker Type (2017E)

  119. MEA Liquid Biopsy Market Value Share By Sample Type (2017E)

  120. MEA Liquid Biopsy Market Value Share By Disease Indication (2017E)

  121. MEA Liquid Biopsy Market Value Share By End User (2017E)

  122. MEA Liquid Biopsy Market Value Share By Region (2017E)

  123. MEA Liquid Biopsy Market Size Analysis, 2012-2016

  124. MEA Liquid Biopsy Market Forecast, 2017–2027

  125. GCC Countries Liquid Biopsy Market Size (US$ Mn) Analysis, 2012–2016

  126. GCC Countries Liquid Biopsy Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027

  127. South Africa Liquid Biopsy Market Size (US$ Mn) Analysis, 2012–2016

  128. South Africa Liquid Biopsy Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027

  129. Rest of MEA Liquid Biopsy Market Size (US$ Mn) Analysis, 2012–2016

  130. Rest of MEA Liquid Biopsy Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027

  131. MEA Liquid Biopsy Market Attractiveness Analysis, By Biomarker Type, 2017–2027 

  132. MEA Liquid Biopsy Market Attractiveness Analysis, By Sample Type, 2017–2027 

  133. MEA Liquid Biopsy Market Attractiveness Analysis, By End User, 2017–2027 

  134. MEA Liquid Biopsy Market Attractiveness Analysis, By Disease Indication, 2017–2027 

  135. MEA Liquid Biopsy Market Attractiveness Analysis, By Region, 2017–2027 

  136. Global Liquid Biopsy Market Y-o-Y Growth (%) Analysis 2017-2027, By Region

  137. Global Liquid Biopsy Market Y-o-Y Growth (%) Analysis 2017-2027, By Region

  138. Global Liquid Biopsy Market Y-o-Y Growth (%) Analysis 2017-2027, By Biomarker Type

  139. Global Liquid Biopsy Market Y-o-Y Growth (%) Analysis 2017-2027, By Biomarker Type

  140. Global Liquid Biopsy Market Y-o-Y Growth (%) Analysis 2017-2027, By Sample Type

  141. Global Liquid Biopsy Market Y-o-Y Growth (%) Analysis 2017-2027, By Sample Type

  142. Global Liquid Biopsy Market Y-o-Y Growth (%) Analysis 2017-2027, By Disease Indication

  143. Global Liquid Biopsy Market Y-o-Y Growth (%) Analysis 2017-2027, By Disease Indication

  144. Global Liquid Biopsy Market Y-o-Y Growth (%) Analysis 2017-2027, By End User

  145. Global Liquid Biopsy Market Y-o-Y Growth (%) Analysis 2017-2027, By End User

  146. Global Liquid Biopsy Market Value Analysis and Forecast, 2016–2027 (US$ Mn)

  147. Global Liquid Biopsy Market Value (US$ Mn), 2012–2016

  148. Global Liquid Biopsy Market Absolute $ Opportunity (US$ Mn), 2016–2027